Meet the Executive Management Team

Our Executive Management Team, with decades of experience in drug discovery, clinical research, pharmaceutical manufacturing, and business administration, oversees business growth, sets strategic direction, and manages daily operations.

  • Martin Rose, MSc

    Chief Executive Officer & Co-founder

    Prior to founding Tetra Pharm Technologies in 2018, Martin spent more than 15 years in various senior positions within the pharmaceutical industry, including at Novo Nordisk, Biogen and FUJIFILM Diosynth Biotechnologies.

    LinkedIn

  • Jesper Breum, MSc

    Chief Quality Officer & Co-founder

    Prior to founding Tetra Pharm Technologies in 2018, Jesper’s professional career of more than 20 years spanned senior roles within the pharmaceutical industry, including at Biogen, CMC Biologics and Bioneer.

    LinkedIn

  • Morten Allesø, PhD

    Chief Scientific Officer

    Morten joined Tetra Pharm Technologies in January 2022. He brings more than 15 years of experience from the pharmaceutical industry, having held roles at Novo Nordisk, Lundbeck, and NNE as researcher in drug formulation development, and lead product and process development scientist.

    LinkedIn

  • Steen Jakobsen, MSc

    Chief Financial Officer

    Steen joined Tetra Pharm Technologies in April 2023. He brings over 24 years of experience in strategic planning, finance, and management, having held leadership roles at The Ministry of Industry, Business and Financial Affairs, Copenhagen Convention Bureau, and Dubai Economy & Tourism.

    LinkedIn

  • Jens Mikkelsen, MD PhD

    Chief Development Officer

    Jens is professor at the University of Copenhagen in translational neuropharmacology, and an experienced researcher with an extensive publication record of more than 300 scientific publications and patents. In addition, Jens has more than 20 years of management experience from the pharmaceutical industry, and he has been involved in bringing several novel drug candidates from early discovery phase to patients.

    LinkedIn

  • Kirsten Harting, MD & eMBA

    Chief Medical Officer

    Kirsten has worked more than 30 years in senior leadership positions in the pharma and biotech industry. She has developed several new medicines, obtained global approval, and secured successful global launches within multiple therapeutic areas. Combining her solid development and commercial understanding, Kirsten has worked at leading companies such as Lundbeck, ALK, Novo Nordisk and LEO Pharma.

    LinkedIn

  • Martin Caspersen, BSc

    Chief Commercial Officer

    Martin joined Tetra Pharm Technologies in July 2021. He brings 25 years of experience in sales, business development, and strategic partnerships, having held various commercial leadership positions, including at Nordea Finance.

    LinkedIn

  • Jacob Schlundt

    Chief Marketing Officer

    Jacob joined Tetra Pharm Technologies in May 2023. He has extensive knowledge and experience in marketing, communication, and event planning, having held leadership positions with Aon and FLSmidth.

    LinkedIn